Prof. Long Yang | Immunology | Best Researcher Award

Tianjin University of Traditional Chinese Medicine | China

AUTHOR PROFILE

LONG YANG, MD & PhD

🎓 EDUCATION

Doctor of Philosophy (PhD), Division of Experimental Medicine, Faculty of Medicine, McGill University, Canada (2005–2009)
Master of Medicine, Division of Pathology and Pathophysiology, Dalian Medical University, China (2000–2003)
Bachelor of Medicine (MD), Division of Clinical Medicine, Dalian Medical University, China (1989–1994)

🏢 EARLY ACADEMIC PURSUITS

Long Yang embarked on a robust academic journey with a foundational education in clinical medicine, followed by a specialization in pathology and pathophysiology. His PhD from McGill University further honed his expertise in experimental medicine, marking the start of an illustrious research career.

💼 PROFESSIONAL ENDEAVORS

Professor (2021–Present)
Institute of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, China.
Focused on advancing integrative medicine through innovative research and teaching.
Research Associate (2018–2020)
Lady Davis Institute, Jewish General Hospital, McGill University, Canada.
Contributed to cutting-edge research in cellular and molecular medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Yang’s research interests lie at the intersection of integrative medicine and experimental cellular mechanisms. He has contributed significantly to understanding infectious diseases and cellular pathophysiology. His work bridges traditional Chinese medicine and contemporary medical research, fostering novel therapeutic strategies.

🌟 IMPACT AND INFLUENCE

Dr. Yang’s tenure in academia and research institutions has been marked by:

Publication of numerous peer-reviewed articles in high-impact journals.
Development of interdisciplinary approaches combining traditional medicine and modern science.
Recognition as a thought leader in cellular and infection microbiology.

📚 ACADEMIC CITATIONS

His research has earned widespread recognition, with citations underscoring the global relevance of his contributions to experimental medicine and integrative healthcare solutions.

🔗 PROFESSIONAL SERVICE

Associate Editor, Frontiers in Cellular and Infection Microbiology.
Played a pivotal role in curating impactful content, ensuring scientific rigor, and promoting advancements in the field.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Long Yang’s work continues to shape the integration of traditional and modern medical paradigms. His dedication to mentoring emerging scholars and contributing to healthcare innovations ensures a lasting legacy in both academia and clinical applications.

🌟CONCLUSION 🌿

Dr. Long Yang’s distinguished career as a researcher, educator, and practitioner showcases his unwavering dedication to advancing medicine through innovation and collaboration. By integrating traditional Chinese medicine with modern scientific methodologies, he has made a profound impact on healthcare, bridging cultural and academic divides.

📊🔬NOTABLE PUBLICATION:

The Gamble Between Oncolytic Virus Therapy and IFN
- Authors: Li, Q., Tan, F., Wang, Y., Yang, L., Cen, S.
- Journal: Frontiers in Immunology
- Year: 2022

Repurposing of HIV/HCV Protease Inhibitors Against SARS-CoV-2 3CLpro
- Authors: Ma, L., Li, Q., Xie, Y., Yang, L., Cen, S.
- Journal: Antiviral Research
- Year: 2022

SERINC5 Restricts Influenza Virus Infectivity
- Authors: Zhao, F., Xu, F., Liu, X., Liang, C., Guo, F.
- Journal: PLoS Pathogens
- Year: 2022

COVID-19 Pandemic: A Multidisciplinary Perspective on the Pathogenesis of a Novel Coronavirus from Infection, Immunity and Pathological Responses
- Authors: Yi, J., Miao, J., Zuo, Q., Kong, X., Yang, L.
- Journal: Frontiers in Immunology
- Year: 2022

Interferon-Inducible SAMHD1 Restricts Viral Replication Through Downregulation of Lipid Synthesis
- Authors: An, N., Ge, Q., Shao, H., Yang, L., Cen, S.
- Journal: Frontiers in Immunology
- Year: 2022

Author Profile

EARLY ACADEMIC PURSUITS

Feryal Dabbagh Gorjani embarked on her academic journey with a strong foundation in the medical sciences. She pursued a B.Sc in Clinical Laboratory from 2008 to 2010 at the Preclinical School of Iran University of Medical Science, Tehran, Iran. Prior to that, she obtained an associated degree in Clinical Laboratory from the Preclinical School of Islamic Azad University, Tehran Medical Sciences Branch, from 2005 to 2007. Her educational journey culminated in an M.Sc in Medical Immunology from 2011 to 2014 at the Medical School of Shiraz University of Medical Science, Shiraz, Iran.

PROFESSIONAL ENDEAVORS

From December 2023 onwards, Feryal Dabbagh Gorjani has been engaged as a medical advisor at Forough Salamat Mehregan, the official representative of the American company Fairhaven Health. Her role in this capacity involves providing expertise and guidance in medical matters, presumably within the realm of immunology and clinical laboratory science.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Throughout her academic and professional journey, Feryal Dabbagh Gorjani has likely contributed to the field of medical immunology and clinical laboratory science. And her Specific research focuses on immunological diagnostics, disease pathogenesis, and therapeutic interventions.

IMPACT AND INFLUENCE

Her work as a medical advisor suggests that she plays a crucial role in shaping decisions related to health and wellness. Her expertise in medical immunology and clinical laboratory science likely contributes to advancements in diagnostic accuracy, treatment efficacy, and patient care.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

Feryal Dabbagh Gorjani's legacy and future contributions lie in her ongoing work as a medical advisor and her potential for further advancements in the fields of medical immunology and clinical laboratory science. As she continues to apply her expertise and knowledge in healthcare settings, her contributions are likely to impact patient outcomes, research advancements, and the broader medical community. Future endeavors may include continued research, publications, and collaborative efforts to address emerging challenges in immunological diagnostics and therapeutics.

Notable Publications

A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases. 2024

COVID-19 and neurological complications. 2022

EcoImmunology: Evaluative Aspects and Future Perspectives. 2018

Investigating the Association of IL-17A and IL-17F with Susceptibility to Preeclampsia in Iranian Women. 2015

Differences in the expression of TLRs and inflammatory cytokines in preeclamptic compared with healthy pregnant women. 2014